← Leaderboards
Thomas Walther
New York University School Of Medicine
$1,480,582
Attributed
$3,619,540
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $857.9K · FY2018–23$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$3,619,540 · 2
By mechanism
R01$3,619,540 · 2
Top collaborators
- Ana Rodriguez12 shared
- Alan Stitt7 shared
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Ana Rodriguez$8,975,691
- Alan Stitt$658,376
- Josef Coresh$115,254,828
- Susan Ruth Schwab$12,737,775
Others in their field
Other Emerging Leaders on “Life”
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Beth Baseler · Leidos Biomedical Research, Inc.$105,136,677
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Martha Hering · Westat, Inc.$57,098,843
Research focus
LifeParasitesEndotheliumIn VitroMalariaMediatingCellsAffectFoundationsIntercellular JunctionsAgonistCerebral MalariaErythrocytesExperimental StudyAngiotensin ReceptorBrain Endothelial CellBloodBlood - Brain Barrier AnatomyEdemaEndothelial CellsAntimalarialsHemorrhageBrainPathology
Grant awards (12)
Targeting the compromised brain endothelial barrier function during cerebral malaria with AT2 receptor agonists$435,542
R01 · FY2023 · HL
Targeting the compromised brain endothelial barrier function during cerebral malaria with AT2 receptor agonists$37,154
R01 · FY2023 · HL
Targeting the compromised brain endothelial barrier function during cerebral malaria with AT2 receptor agonists$435,542
R01 · FY2022 · HL
Regulation of brain endothelial integrity by angiotensin receptors as treatment for cerebral malaria$322,039
R01 · FY2022 · NS
Targeting the compromised brain endothelial barrier function during cerebral malaria with AT2 receptor agonists$97,903
R01 · FY2022 · HL
Targeting the compromised brain endothelial barrier function during cerebral malaria with AT2 receptor agonists$435,542
R01 · FY2021 · HL
Regulation of brain endothelial integrity by angiotensin receptors as treatment for cerebral malaria$324,464
R01 · FY2021 · NS
Targeting the compromised brain endothelial barrier function during cerebral malaria with AT2 receptor agonists$97,903
R01 · FY2021 · HL
Targeting the compromised brain endothelial barrier function during cerebral malaria with AT2 receptor agonists$435,542
R01 · FY2020 · HL
Regulation of brain endothelial integrity by angiotensin receptors as treatment for cerebral malaria$326,701
R01 · FY2020 · NS
Regulation of brain endothelial integrity by angiotensin receptors as treatment for cerebral malaria$324,953
R01 · FY2019 · NS
Regulation of brain endothelial integrity by angiotensin receptors as treatment for cerebral malaria$346,255
R01 · FY2018 · NS